Key facts
- Applied Monitoring’s last known valuation is $2.0M (Feb 2025).
- It has raised $1.5M; the latest was Later Stage VC ($690K) in Feb 2025.
- Notable investors include Mercia Ventures, Maven Capital Partners UK, Centre for Process Innovation, European Structural And Investment Funds, North East Fund.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Applied Monitoring
- ·The full record, as it builds
Funding rounds
No funding rounds for Applied Monitoring are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Applied Monitoring
Developer of dermal sensors designed for monitoring and transformation in blood testing. The company's sensor range addresses current blood science in sectors including alcohol misuse, drug and substance misuse, healthcare, sports, and the pharmaceutical industry, enabling healthcare professionals to have access to sensors for alcohol and drug detection.
- Sector
- Healthcare
- HQ
- Sunderland, United Kingdom
- Founded
- 2018
- Employees
- 3
- Website
- appliedmonitoring.co.uk/
- Ownership
- Privately Held (backing)
Applied Monitoring doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Applied Monitoring shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Applied Monitoring in its N-PORT filings yet. We sweep new filings monthly.